公开(公告)号：US20240246928A1

公开(公告)日：2024-07-25

申请号：US18526960

申请日：2023-12-01

Applicant: NEUMORA THERAPEUTICS, INC.

Inventor： Paul Dransfield ,  Dilinie Fernando ,  James Harvey ,  Brian Sparling ,  John Stellwagen ,  Zhihua Ma ,  Anne-Marie Beausoleil ,  Ryan Hudson

IPC: C07D401/04

CPC classification number: C07D401/04

Abstract: The present disclosure relates to compounds of Formula (I),




and pharmaceutically acceptable salts thereof, wherein the variable are as described herein, and compositions and uses of same for treating neurological disorders.

公开(公告)号：US20240294492A1

公开(公告)日：2024-09-05

申请号：US18628594

申请日：2024-04-05

Applicant: NEUMORA THERAPEUTICS, INC.

Inventor： Paul Dransfield ,  Dilinie Fernando ,  James Harvey ,  Brian Sparling ,  John Stellwagen ,  Zhihua Ma ,  Anne-Marie Beausoleil ,  Ryan Hudson

IPC: C07D401/04

CPC classification number: C07D401/04

Abstract: The present disclosure relates to compounds of Formula (I).




and pharmaceutically acceptable salts thereof, wherein the variable are as described herein, and compositions and uses of same for treating neurological disorders.

公开(公告)号：US11993580B1

公开(公告)日：2024-05-28

申请号：US18526960

申请日：2023-12-01

Applicant: NEUMORA THERAPEUTICS, INC.

Inventor： Paul Dransfield ,  Dilinie Fernando ,  James Harvey ,  Brian Sparling ,  John Stellwagen ,  Zhihua Ma ,  Anne-Marie Beausoleil ,  Ryan Hudson

IPC: C07D401/04

CPC classification number: C07D401/04

Abstract: The present disclosure relates to compounds of Formula (I),




and pharmaceutically acceptable salts thereof, wherein the variable are as described herein, and compositions and uses of same for treating neurological disorders.